180 related articles for article (PubMed ID: 35596772)
1. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases.
Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
[TBL] [Abstract][Full Text] [Related]
2. TNF-α Indicates Radiation-induced Liver Injury After Interstitial High Dose-rate Brachytherapy.
Damm R; Pech M; Haag F; Cavalli P; Gylstorff S; Omari J; Seidensticker R; Ricke J; Seidensticker M; Relja B
In Vivo; 2022; 36(5):2265-2274. PubMed ID: 36099091
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
Seidensticker M; Seidensticker R; Damm R; Mohnike K; Pech M; Sangro B; Hass P; Wust P; Kropf S; Gademann G; Ricke J
PLoS One; 2014; 9(11):e112731. PubMed ID: 25393877
[TBL] [Abstract][Full Text] [Related]
4. Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases.
Powerski M; Penzlin S; Hass P; Seidensticker R; Mohnike K; Damm R; Steffen I; Pech M; Gademann G; Ricke J; Seidensticker M
Strahlenther Onkol; 2019 Mar; 195(3):265-273. PubMed ID: 30470846
[TBL] [Abstract][Full Text] [Related]
5. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial.
Damm R; Wybranska J; Hass P; Walke M; Omari J; Pech M; Seidensticker R; Ricke J; Seidensticker M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9043-9049. PubMed ID: 37166579
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
Rühl R; Lüdemann L; Czarnecka A; Streitparth F; Seidensticker M; Mohnike K; Pech M; Wust P; Ricke J
Radiat Oncol; 2010 May; 5():44. PubMed ID: 20507615
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation, logistics and workflow guide for MRI image based interstitial HDR brachytherapy for gynecological cancers.
Zhang H; Donnelly ED; Strauss JB; Kang Z; Gopalakrishnan M; Lee PC; Khelashvili G; Nair CK; Lee BH; Sathiaseelan V
J Appl Clin Med Phys; 2019 Nov; 20(11):37-49. PubMed ID: 31600015
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.
Omari J; Heinze C; Wilck A; Hass P; Seidensticker M; Seidensticker R; Mohnike K; Ricke J; Pech M; Powerski M
Eur J Radiol; 2019 Mar; 112():22-27. PubMed ID: 30777214
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience.
Drewes R; Omari J; Manig M; Seidensticker M; Hass P; Ricke J; Powerski M; Pech M
J Contemp Brachytherapy; 2019 Aug; 11(4):329-336. PubMed ID: 31523233
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
12. Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy.
Omari J; Heinze C; Damm R; Hass P; Janitzky A; Wendler JJ; Seidensticker M; Ricke J; Powerski MJ; Pech M
Anticancer Res; 2019 May; 39(5):2501-2508. PubMed ID: 31092445
[TBL] [Abstract][Full Text] [Related]
13. Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient.
Appalanaido GK; Ahmad MZ; Shukor SA; Cheen Hoe AK; Subramaniam MK; Fan AS; Abdul Aziz MZ
Hepat Oncol; 2022 Sep; 9(3):HEP44. PubMed ID: 36176484
[TBL] [Abstract][Full Text] [Related]
14. Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.
Seidensticker M; Seidensticker R; Mohnike K; Wybranski C; Kalinski T; Luess S; Pech M; Wust P; Ricke J
Radiat Oncol; 2011 Apr; 6():40. PubMed ID: 21496320
[TBL] [Abstract][Full Text] [Related]
15. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
Strnad V; Lotter M; Grabenbauer G; Sauer R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
[TBL] [Abstract][Full Text] [Related]
16. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study.
Seidensticker M; Burak M; Kalinski T; Garlipp B; Koelble K; Wust P; Antweiler K; Seidensticker R; Mohnike K; Pech M; Ricke J
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):213-21. PubMed ID: 24610229
[TBL] [Abstract][Full Text] [Related]
18. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
[TBL] [Abstract][Full Text] [Related]
19. Interstitial brachytherapy vs. intensity-modulated radiation therapy for patients with cervical carcinoma not suitable for intracavitary radiation therapy.
Sharma DN; Gandhi AK; Sharma S; Rath GK; Jagadesan P; Julka PK
Brachytherapy; 2013; 12(4):311-6. PubMed ID: 23466359
[TBL] [Abstract][Full Text] [Related]
20. Interstitial brachytherapy guided intensity modulated radiation therapy (IBGIMRT) in cervical cancer: a dosimetric study.
Sharma DN; Subramani V; Rath GK; Jothybasu KS; Bahl A; Julka PK; Gopishankar N
J Contemp Brachytherapy; 2009 Jun; 1(2):87-91. PubMed ID: 27795717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
